Pure Global

IMMUCOR INC. - Authorized Company ProfileIMMUCOR INC.

Explore comprehensive authorized company profile for IMMUCOR INC. through Pure Global AI's free Colombia medical device database. This company manufactures 74 medical devices registered with INVIMA across 3 risk classes. Their registration history spans from Sep 30, 2021 to Apr 03, 2030.

This page provides detailed insights including recent registrations, risk class distribution (III: 61, IIa: 3, II: 10), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
74 Devices
3 Risk Classes
IMMUCOR INC.
IMMUCOR INC.
Authorized Company
74
Total Devices
3
Risk Classes
2021
Earliest
2030
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

ANTI-S (MONOCLONAL) GAMMA-CLONE, IMMUCLONE

ANTI-S (MONOCLONAL) GAMMA-CLONE, IMMUCLONE

9ecd10e7b2130109dd8a2b930274c1e0

III
Apr 03, 2030

GAMMA N-HANCE

GAMMA N-HANCE

94b5c2184ac494da4f5b92e15ef3e15b

II
Jan 02, 2030

GAMMA PEG

GAMMA PEG

8c0ed296e95be82ec85799e5c3f6c16b

II
Jan 02, 2030

REST (RABBIT ERYTHROCYTE STROMA) MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

REST (RABBIT ERYTHROCYTE STROMA) MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

1af2279d08378508e42190e02ff22312

II
Nov 21, 2029

W.A.R.M. (WARM AUTOANTIBODY REMOVAL MEDIUM), MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

W.A.R.M. (WARM AUTOANTIBODY REMOVAL MEDIUM), MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

f341c158920c1e4a8f979bac881aa2d6

II
Nov 21, 2029

GAMMAZYME-F MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

GAMMAZYME-F BRAND NAMES: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

d34ce5efb28b3e152fa88ba4d4ac2ca3

II
Nov 21, 2029

GAMMA EGA KIT MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

GAMMA EGA KIT MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

070d11d6f6414187d9e3491435d46edb

II
Nov 21, 2029

FREEZE DRIED PAPAIN MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA

FREEZE DRIED PAPAIN MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA

470de483c03744ffe73be0103a93403d

II
Nov 21, 2029

GAMMA - QUIN MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

RANGE - WHICH BRANDS: IMMUCLONE, NOVACLONE, IMMUCOR RANGE.

9f64c0dc97aa5d4e5ec671af17cf5f81

II
Nov 21, 2029

BROMELIN MARCAS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

BROMELIN BRANDS: IMMUCLONE, NOVACLONE, IMMUCOR GAMMA.

a129b5642bdfcde3e9fbf590e43e4ff7

II
Nov 21, 2029

BLOOD BANK ANALIZER- ANALIZADOR DEE BANCO DE SANGRE GALILEO Y GALILEO ECHO

BLOOD BANK ANALYZER AND GALILEO ECHO

be747be901a11d0d8e111d2f1fd8a7bf

IIa
Jan 04, 2029

CAPTURE-Pยฎ READY-SCREEN

CAPTURE-Pยฎ READY-SCREEN

b977a968c4ceef8a3248dd42869f4f4a

III
Jun 02, 2027

ANTI-JKA (MONOCLONAL) MARCAS: GAMMA-CLONE, IMMUCOR GAMMA

ANTI-JKA (MONOCLONAL) MARCAS: GAMMA-CLONE, IMMUCOR GAMMA

4c1a7c739d29ae8fbdb3cccaba9a4b68

III
May 26, 2027

PWSS PLATELET WASH AND STORAGE SOLUTION

PWSS PLATELET WASH AND STORAGE SOLUTION

0d002ff2222487669a6ee769aebfdea4

III
Jan 12, 2027

REFERENCELLS-1 (A2)

REFERENCELLS-1 (A2)

bdaf00906e0ec6b8342fad2ec63ab83c

III
Jan 10, 2027

REFERENCELLS-2 (A 1, B)

REFERENCELLS-2 (A 1, B)

f006143af3198331edd449e619cf1a7b

III
Jun 29, 2026

NOVACLONEโ„ข ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT

NOVACLONEโ„ข ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT

87c6fc59f71d1d3aff4195004ba3233c

III
Jun 28, 2026

ANTI-C3B,-C3D(MURINE MONOCLONAL) MARCAS IMMUCOR GAMMA, GAMMA-CLONE

ANTI-C3B,-C3D(MURINE MONOCLONAL) MARCAS IMMUCOR GAMMA, GAMMA-CLONE

dcb94d3b62480fe48bc099db3b267dd5

III
Jun 16, 2026

CORQC EXTEND MARCAS: IMMUCOR GAMMA, IMMUCOR

CORQC EXTEND MARCAS: IMMUCOR GAMMA, IMMUCOR

53dd7785643b40c25a75ee1ac979932d

III
Jun 04, 2026

NOVACLONEโ„ข ANTI-C (RH4) HUMAN MONOCLONAL IGM RH TYPING REAGENTS

NOVACLONEโ„ข ANTI-C (RH4) HUMAN MONOCLONAL IGM RH TYPING REAGENTS

2d7aee941c0b262e9284886e90afcf2b

III
May 14, 2026
Risk Class Distribution
Devices by risk class
III
61
82.4% of total
II
10
13.5% of total
IIa
3
4.1% of total